W R GRACE AND CO -CONN

W R GRACE AND CO -CONN (United States) holds 14 active US FDA Type II Drug Master Files and 1 inactive, has DMF or CEP filings on record for 15 active ingredients, holds 1 active Type IV (excipient) Drug Master File and is linked to 1 FDA-registered manufacturing site. No FDA recall, Warning Letter or Form 483 record is linked to it, which is not proof that none exists.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “W R GRACE AND CO -CONN: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/w-r-grace-and-co-conn

Overview

W R GRACE AND CO -CONN is an active pharmaceutical ingredient (API) supplier with 16 active FDA Type II Drug Master Files, covering BENAZEPRIL HYDROCHLORIDE; BENZONATATE USP; DIPHENHYDRAMINE CITRATE, USP; FENOPROFEN CALCIUM, USP+BP; FLURBIPROFEN USP & BP; ITRACONAZOLE USP & PH EUR.

Core services & business areas

API Manufacturing

Active ingredients with DMF or CEP filings

Substances for which W R GRACE AND CO -CONN holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.

API / Drug Master Files

W R GRACE AND CO -CONN holds 14 active (15 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • BENAZEPRIL HYDROCHLORIDEActive2000-02-21
  • MILRINONE USPActive1999-08-31
  • PRAMOXINE HYDROCHLORIDEActive1998-09-24
  • TERCONAZOLEActive1998-02-19
  • ITRACONAZOLE USP & PH EURActive1997-10-16
  • LIDOCAINE USPActive1995-06-05
  • DIPHENHYDRAMINE CITRATE, USPActive1994-09-23
  • TETRACAINE HCLActive1989-09-21
  • FENOPROFEN CALCIUM, USP+BPActive1987-03-03
  • PROPRANOLOL HYDROCHLORIDEActive1985-06-05
  • ORPHENADRINE CITRATE USPActive1985-02-22
  • BENZONATATE USPActive1983-12-13
  • PROCAINAMIDE HYDROCHLORIDEActive1983-04-18
  • LIDOCAINE HCL, USP, BP & PH EURActive1981-11-10
  • AMIFOSTINEInactive2009-06-26

Excipient Drug Master Files

W R GRACE AND CO -CONN holds 1 active (1 total) FDA Type IV Drug Master File. A Type IV DMF covers an excipient, colourant or flavour, not an active ingredient; these are counted separately from the API filings above.

  • SYLOID - SILICA PRODUCTS (SILICA GEL)Active1965-12-16

Registered manufacturing sites (1)

Physical sites registered with the US FDA and resolved to W R GRACE AND CO -CONN, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to W R GRACE AND CO -CONN in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.

For suppliers

Is this W R GRACE AND CO -CONN?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.